Risks and benefits of celecoxib to prevent recurrent adenomas

被引：69

作者：

Psaty, Bruce M. ^{[1
]}

Potter, John D.

机构：

[1] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA

[2] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA

[3] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA

[4] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 355卷 / 09期

关键词：

D O I：

10.1056/NEJMe068158

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：950 / 952

页数：3

共 19 条

[1] Celecoxib for the prevention of colorectal adenomatous polyps [J].

Arber, Nadir ;

Eagle, Craig J. ;

Spicak, Julius ;

Racz, Istvan ;

Dite, Petr ;

Hajer, Jan ;

Zavoral, Miroslav ;

Lechuga, Maria J. ;

Gerletti, Paola ;

Tang, Jie ;

Rosenstein, Rebecca B. ;

Macdonald, Katie ;

Bhadra, Pritha ;

Fowler, Robert ;

Wittes, Janet ;

Zauber, Ann G. ;

Solomon, Scott D. ;

Levin, Bernard .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :885-895

[2] A randomized trial of aspirin to prevent colorectal adenomas [J].

Baron, JA ;

Cole, BF ;

Sandler, RS ;

Haile, RW ;

Ahnen, D ;

Bresalier, R ;

McKeown-Eyssen, G ;

Summers, RW ;

Rothstein, R ;

Burke, CA ;

Snover, DC ;

Church, TR ;

Allen, JI ;

Beach, M ;

Beck, GJ ;

Bond, JH ;

Byers, T ;

Greenberg, ER ;

Mandel, JS ;

Marcon, N ;

Mott, LA ;

Pearson, L ;

Saibil, F ;

van Stolk, RU .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) :891-899

[3] Celecoxib for the prevention of sporadic colorectal adenomas [J].

Bertagnolli, Monica M. ;

Eagle, Craig J. ;

Zauber, Ann G. ;

Redston, Mark ;

Solomon, Scott D. ;

Kim, KyungMann ;

Tang, Jie ;

Rosenstein, Rebecca B. ;

Wittes, Janet ;

Corle, Donald ;

Hess, Timothy M. ;

Woloj, G. Mabel ;

Boisserie, Frederic ;

Anderson, William F. ;

Viner, Jaye L. ;

Bagheri, Donya ;

Burn, John ;

Chung, Daniel C. ;

Dewar, Thomas ;

Foley, T. Raymond ;

Hoffman, Neville ;

Macrae, Finlay ;

Pruitt, Ronald E. ;

Saltzman, John R. ;

Salzberg, Bruce ;

Sylwestrowicz, Thomas ;

Gordon, Gary B. ;

Hawk, Ernest T. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (09) :873-884

[4]

Bresalier RS, 2006, NEW ENGL J MED, V355, P221

[5] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].

Bresalier, RS ;

Sandler, RS ;

Quan, H ;

Bolognese, JA ;

Oxenius, B ;

Horgan, K ;

Lines, C ;

Riddell, R ;

Morton, D ;

Lanas, A ;

Konstam, MA ;

Baron, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102

[6] Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer [J].

Chan, AT ;

Giovannucci, EL ;

Meyerhardt, JA ;

Schernhammer, ES ;

Curhan, GC ;

Fuchs, CS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (08) :914-923

[7] Low-dose aspirin in the primary prevention of cancer the women's health study: A randomized controlled trial [J].

Cook, NR ;

Lee, IM ;

Gaziano, JM ;

Gordon, D ;

Ridker, PM ;

Manson, JE ;

Hennekens, CH ;

Buring, JE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (01) :47-55

[8] LOW-DOSE ASPIRIN AND INCIDENCE OF COLORECTAL TUMORS IN A RANDOMIZED TRIAL [J].

GANN, PH ;

MANSON, JE ;

GLYNN, RJ ;

BURING, JE ;

HENNEKENS, CH .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (15) :1220-1224

[9] Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities [J].

Grosser, T ;

Fries, S ;

FitzGerald, GA .

JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :4-15

[10] Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the US Preventive Services Task Force [J].

Hayden, M ;

Pignone, M ;

Phillips, C ;

Mulrow, C .

ANNALS OF INTERNAL MEDICINE, 2002, 136 (02) :161-172

← 1 2 →